SCHEMBL8869129

SCHEMBL8869129

CC(C)OC(=O)CNC(=O)c1ccc(C(=O)NS(=O)(=O)c2ccc(C(=O)NCCc3ccc(F)cc3)cc2)cn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.49
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
BCL2L1 Q07817 1/20 0.42
MCL1 Q07820 1/20 0.42
P4HTM Q9NXG6 2/20 0.42
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
PPARA Q07869 1/20 0.42
LMNA P02545 2/20 0.41
TP53 P04637 1/20 0.41
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
CYP3A4 P08684 1/20 0.41
HTR1A P08908 1/20 0.41
CYP2C9 P11712 1/20 0.41
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8868676 1.00 MAPT (0.49) MAPTMEN1KMT2ABCL2L1MCL1
SCHEMBL8869489 0.92 PPARA (0.50) MAPTMEN1KMT2ABCL2L1MCL1
SCHEMBL8868754 0.92 PPARA (0.48) MAPTMEN1KMT2AP4HTMPPARA
SCHEMBL8869237 0.92 PPARA (0.50) MAPTMEN1KMT2ABCL2L1MCL1
SCHEMBL8868842 0.92 P4HTM (0.48) MAPTMEN1KMT2AP4HTMPPARA
SCHEMBL8868685 0.91 MAPT (0.52) MAPTMEN1KMT2ABCL2L1MCL1
SCHEMBL8868460 0.91 MAPT (0.52) MAPTMEN1KMT2ABCL2L1MCL1
SCHEMBL9140344 0.91 MAPT (0.53) MAPTMEN1KMT2ABCL2L1MCL1
SCHEMBL9140652 0.91 MAPT (0.53) MAPTMEN1KMT2ABCL2L1MCL1
SCHEMBL8869223 0.91 P4HTM (0.55) MAPTMEN1KMT2AP4HTMPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed